Silence Therapeutics plc (FRA:XRP2)

Silence Therapeutics Revenue

Silence Therapeutics had revenue of $159.00K USD in the quarter ending September 30, 2025, a decrease of -89.39%. This brings the company's revenue in the last twelve months to $25.83M, up 18.13% year-over-year. In the year 2024, Silence Therapeutics had annual revenue of $41.20M with 27.54% growth.

• Revenue (ttm): $25.83M
• Revenue Growth: +18.13%
• P/S Ratio: 8.70
• Revenue / Employee: $222.67K
• Employees: 116
• Market Cap: 191.63M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	41.20M	8.90M	27.54%
Dec 31, 2023	32.30M	10.65M	49.17%
Dec 31, 2022	21.66M	4.87M	29.01%
Dec 31, 2021	16.78M	9.29M	124.07%
Dec 31, 2020	7.49M	7.17M	2,215.11%
Dec 31, 2019	323.57K	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	21.62K	-928.69K	-97.72%
Dec 31, 2016	950.31K	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	23.37K	-170.40K	-87.94%
Dec 31, 2013	193.77K	-	-